TRIP13 promotes lung cancer cell growth and metastasis through AKT/mTORC1/c-Myc signaling

Abstract

Our results have identified the role and potential mechanism by which TRIP13 affects LUAD cells, which may provide a useful marker for helping to diagnose this disease and create new therapies against it.